National Research Corp Market Cap ($462.71 Million)
Market Cap & Net Worth: National Research Corp (NRC)
National Research Corp market cap. National Research Corp (NASDAQ:NRC) has a market capitalization of $462.71 Million ($462.71 Million) as of October 31, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #12281 globally and #3102 in its home market, demonstrating a 11.46% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying National Research Corp's stock price $23.83 by its total outstanding shares 22139315 (22.14 Million).
National Research Corp Market Cap History (2015–2026)
National Research Corp market cap history from 2015 to 2026. Data shows growth from $301.58 Million to $527.58 Million (6.89% CAGR). Check National Research Corp (NRC) stock price for real-time trading data and today's change.
Index Memberships
National Research Corp is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.62 Trillion | 0.02% | #335 of 976 |
|
NASDAQ Composite
IXIC
|
$40.09 Trillion | 0.00% | #1236 of 3165 |
Weight: National Research Corp's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
National Research Corp Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how National Research Corp's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see National Research Corp (NRC) cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
3.02x
National Research Corp's market cap is 3.02 times its annual revenue
Latest Price to Earnings (P/E) Ratio
35.82x
National Research Corp's market cap is 35.82 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $365.16 Million | $109.38 Million | $20.52 Million | 3.34x | 17.80x |
| 2017 | $727.04 Million | $117.56 Million | $22.94 Million | 6.18x | 31.69x |
| 2018 | $766.10 Million | $119.69 Million | $30.05 Million | 6.40x | 25.50x |
| 2019 | $1.34 Billion | $127.98 Million | $32.41 Million | 10.50x | 41.47x |
| 2020 | $875.47 Million | $133.28 Million | $37.26 Million | 6.57x | 23.50x |
| 2021 | $859.23 Million | $147.95 Million | $37.47 Million | 5.81x | 22.93x |
| 2022 | $788.18 Million | $151.57 Million | $31.80 Million | 5.20x | 24.79x |
| 2023 | $863.95 Million | $148.58 Million | $30.97 Million | 5.81x | 27.90x |
| 2024 | $390.54 Million | $143.06 Million | $24.78 Million | 2.73x | 15.76x |
| 2025 | $415.55 Million | $137.39 Million | $11.60 Million | 3.02x | 35.82x |
Competitor Companies of NRC by Market Capitalization
Companies near National Research Corp in the global market cap rankings as of October 31, 2026. See NRC equity financing ratio to understand what proportion of total assets are financed by equity.
Key companies related to National Research Corp by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of National Research Corp (2015–2026)
Market capitalization of National Research Corp from 2015 to today. Between 2015 and today, National Research Corp's market cap moved from $301.58 Million to $ 527.58 Million, with a yearly change of 6.89%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $527.58 Million | +26.96% |
| 2025 | $415.55 Million | +6.41% |
| 2024 | $390.54 Million | -54.80% |
| 2023 | $863.95 Million | +9.61% |
| 2022 | $788.18 Million | -8.27% |
| 2021 | $859.23 Million | -1.86% |
| 2020 | $875.47 Million | -34.85% |
| 2019 | $1.34 Billion | +75.41% |
| 2018 | $766.10 Million | +5.37% |
| 2017 | $727.04 Million | +99.10% |
| 2016 | $365.16 Million | +21.08% |
| 2015 | $301.58 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of National Research Corp was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $462.71 Million USD |
| MoneyControl | $462.71 Million USD |
| MarketWatch | $462.71 Million USD |
| marketcap.company | $462.71 Million USD |
| Reuters | $462.71 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About National Research Corp
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, an… Read more